Resultado de búsqueda
Hace 5 días · Benzinga: Petros is pursuing increased access for its flagship prescription erectile dysfunction therapy, Stendra (avanafil), vi potential OTC designation.
Hace 4 días · Petros Pharmaceuticals, Inc. (PTPI) Stock Earnings Dates & Report.
Hace 5 días · Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for ...
Hace 4 días · Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) posted its quarterly earnings data on Wednesday, May, 15th. The company reported ($2.05) earnings per share (EPS) for the quarter. The firm earned $1.39 million during the quarter. Petros Pharmaceuticals had a negative trailing twelve-month return on equity of 102.32% and a negative net ...
- (973) 242-0005
- 1185 AVENUE OF THE AMERICAS 3RD FLOOR, NEW YORK NY, 10036
- jbenison@neurotropebioscience.com
Hace 3 días · (NASDAQ: PTPI) Petros Pharmaceuticals currently has 7,000,195 outstanding shares. With Petros Pharmaceuticals stock trading at $0.41 per share, the total value of Petros Pharmaceuticals stock (market capitalization) is $2.86M.
Hace 4 días · Financial Advisor at Raymond James. 1mo. Contracts linked to the S&P 500, Dow Jones Industrial Average, and Nasdaq 100 indicate a flattish open. Market participants are in wait-and-see mode in...
Hace 5 días · Financial Advisor at Raymond James.
